Member Info for StarBright

Update: Some larger trades on the tape now. Looks like someone is buying in 500k parcels. A 1m buy also printed this morning.

Good RNS this morning. I like the straightforward factual style as well as the content.

+34% at this point, but only small (largest is just £11k) PI-type trades printed so far. Plenty of scope for more interesting prints later on.

I think simply to stimulate interest and demand for the shares. Whilst AVCT has been hawked around generalist / small-cap desks for several years it hasn't gained much traction. With - we hope! - some interesting science to share (some sector investors have sciencey academic backgrounds and love a bit of detail...) there's an opportunity to reinvigorate the company's narrative. Perhaps especially if there's been a bit of upward sp momentum. The febrile PI base seen here and on Twitter every day isn't ideal for an ambitious company, particularly if you have one eye on a trade sale in the next few years. A recycling toward institutional holders would be beneficial, but it's very hard to achieve as shown by several high-profile AIM companies.

That the company is running this should be seen as a positive.

FFS. It's Jan 10th. Any release made this week (at least) would be "early January".

A few US transactions with nice premiums today… Amryt, Cincor, Albireo

I think they were just smart and acted quickly when the Covid resurgence story prompted some PI interest in NCYT. At a time of low liquidity, a few well placed trades on the Paris exchange plus a bit of Twitter chat combined with the difference in re-opening days created a nice little window to sell into. Not planned in advance, but v nicely executed… All imho.

“Follow the money” suggests that Biosynex were behind the pump - as they evidently took advantage to dump. Nicely executed to be fair.

@TheGord - the order book is completely empty other than the RSP marks. What prompted your comment that “something big is brewing”?

Whether or not AVCT is “poorly researched” is an interesting question. There is a significant body of research in the public domain, and this board is very good at sign-posting it. The problem is more one of poor conclusions than poor research. And poor conclusions in this context encompasses both rampers and de-rampers. This share is notable for the nonsense from ultras on both sides - posts today suggesting that shareholders equity will be subsumed by the death spiral are as ridiculous as posts suggesting that AVCT could reach an MCap of $40bn+ should AVA6k be successful. Inexperienced investors should tread carefully.

I’m out at an average of 147p for an unpleasant loss across the last year or so since I made the mistake of buying in. Looks like a (french!) pump and dump to me, orchestrated to exploit a transient spike in covid coverage coincident with a quiet period in markets. I’m happy it’s given me a chance to escape with a little dignity from a position that was nearly -70% at one point. Some lessons re-learned here.

I could well be wrong! My instincts with NCYT have been poor. Who knows, there may be an RNS this week with news of DHSC settlement, new orders etc. I will be pleased for LTH’s choosing to hold, but for me enough is enough. I won’t be buying back in. GLA.

10k at market order. Some people will never learn..!

Should be an interesting first few minutes.

Your frantic scaremongering is misinformed and misplaced. Give it a rest please.

NY size buyers locked out today ;>

Can you not give the repeated NY nonsense a rest @Hurst10…? Every day you try your best to assert that “NY” are coming over the hill around US opening time. It really is nonsense! The reality is that AVCT’s sp has traded in the 120p +/- 20p channel since April, and will move ONLY when there is concrete news. Many of us are hoping that this will be soon with the trailed announcement(s) in q1 this year. At that point all being well we can perhaps look for your fabled Yankee stampede, but until then I really wouldn’t bother…

There is - in any case - probably a greater concentration of LS investors on the west coast than there are in NYC, and I guarantee that the opening time of the NY exchange is entirely irrelevant to all of them.

@carpfisher, the trade printed this morning is 10m x 0.521p. The RNS reporting Rod Creosote’s purchase says 10m x 0.489755p. Not the same trade.

The sheer volume of brass-necked troughing here may well indicate that an inflexion point is incoming. If not it’ll be a horrible look for Rod McIllree, who has been gorging himself on LTH’s upside potential and is now stuffed to the gills like Mr Creosote…

MrRipley I’m sorry you’ve chosen to respond like that. I had thought you were sophisticated enough to recognise when someone was tweaking your tail…

Oh look - an angry trader!

I wouldn’t expect anything in the first week of the New Year, as desks will still be short-staffed especially seniors. The weeks of Jan 9th and 16th will likely be prime time for impactful announcements as everyone will be on deck and keen to get their calendar year off to a good start….

Thank you for sharing your trading plan MrRipley. It’s helpful for investors here to understand that you’ll be looking to take profits when the re-rate comes.

Can we take it you won’t be operating in full-on Rawhide mode whipping the next spike along whilst selling into it…?